Patterns of baseline characteristics also did not change meaningfully when we ascertained our exposures for CKD-MBD out-of- or above-target composite scores using a PTH range of 150–300 pg/mL rather than 150–600 pg/mL (Additional file 1: Table S1). The gene discussed is PTH; the disease is chronic kidney disease.